Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study
By J. Foucher, E. Chanteloup, J. Vergniol, Laurent Castéra, B. Bail, X. Adhoute, J. Bertet, P. Couzigou, V. Ledinghen. Gut, 2005
1,343 citations recorded by the source corpus.
Subfields: Epidemiology, Hepatology
View Paper: https://www.semanticscholar.org/paper/5b9b891f22c1f0c81a4267b69d8ed1d10c3caa5d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Hepatology
Citations in the corpus
- Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. (2008, neutral): “…2003 0.88 0.91 0.99 Ziol et al, 2005 0.79 8.8 56 91 0.91 9.6 86 85 0.97 14.6 86 96 Castera et al, 2005 0.83 7.1 67 89 0.90 9.5 73 91 0.95 12.5 87 91 Foucher et al, 2006 0.80 7.2 64 85 0.90 12.5 65 95 0.96 17.6 77 97 Coletta et al, 2005 1.00 8.74 100 100 9.6 de Ledinghen et al, 2006 0.72 4.5 93 18…”
- Shear Wave Spectroscopy for In Vivo Quantification of Human Soft Tissues Visco-Elasticity (2009, background): “Liver fibrosis is currently characterized in elastography by the assessment of shear elasticity at a fixed frequency [15].”
- Noninvasive assessment of liver fibrosis (2011, background): “Other studies have reached similar conclusions.(61) It is important to remember, however, that the correlation between portal pressure and liver stiffness decreases when hepatic venous pressure gradient values exceed 12 mm Hg.”
- Non-invasive evaluation of liver fibrosis using transient elastography. (2008, background): “Preliminary results from our group [19] suggest that liver stiffness values in cirrhotic patients may increase as liver disease becomes more advanced.”
- Quantifying hepatic shear modulus in vivo using acoustic radiation force. (2008, methodology): “These shear moduli represent those reported for healthy through cirrhotic livers (Foucher et al., 2006; Sandrin et al., 2003).”
- WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 3: liver. (2015, background): “TE has also been evaluated in cholestatic liver diseases (Corpechot et al. 2012, Corpechot et al. 2006b), in a variety of chronic liver diseases (Foucher et al. 2006a; Fraquelli et al. 2007; Ganne-Carrie et al. 2006) as well as in alcoholic liver disease (Nahon et al. 2008; Nguyen-Khac et al. 2008).”
- EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. (2015, background): “TE has also been evaluated in a variety of chronic liver diseases [56,144,162], as well as in primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) [163,164], and ALD [151,165] (Table 6).”